Skip to search formSkip to main contentSkip to account menu

Cabometyx

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

cabozantinib
cabozantinib 60 MG Oral Tablet [Cabometyx]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cabometyx (Cabozantinib) Tablets First Multikinase Inhibitor Approved for the Treatment of Patients with Advanced Renal-Cell Carcinoma
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)